Alexion Pharmaceuticals, Inc.
Inhibitors of protein kinases
Last updated:
Abstract:
The present invention is directed to methods of treating multiple myeloma by administering a compound of Formula (I) ##STR00001## or pharmaceutically acceptable salt thereof.
Status:
Grant
Type:
Utility
Filling date:
26 Nov 2019
Issue date:
16 Aug 2022